Last reviewed · How we verify
Folic acid or folate — Competitive Intelligence Brief
phase 3
Vitamin B9 / Folate supplement
Dihydrofolate reductase (DHFR) / Folate metabolism pathway
Nutritional supplementation / Hematology / Obstetrics
Small molecule
Live · refreshed every 30 min
Target snapshot
Folic acid or folate (Folic acid or folate) — Hoffmann-La Roche. Folic acid acts as a coenzyme in one-carbon transfer reactions essential for DNA synthesis and cell division.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Folic acid or folate TARGET | Folic acid or folate | Hoffmann-La Roche | phase 3 | Vitamin B9 / Folate supplement | Dihydrofolate reductase (DHFR) / Folate metabolism pathway |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape (Vitamin B9 / Folate supplement class)
- Hoffmann-La Roche · 1 drug in this class
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Folic acid or folate CI watch — RSS
- Folic acid or folate CI watch — Atom
- Folic acid or folate CI watch — JSON
- Folic acid or folate alone — RSS
- Whole Vitamin B9 / Folate supplement class — RSS
Cite this brief
Drug Landscape (2026). Folic acid or folate — Competitive Intelligence Brief. https://druglandscape.com/ci/folic-acid-or-folate. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab